|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 149 | 2002 | Challenges in the methodology for the validation of surrogate endpoints in randomized trials | MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier; BURZYKOWSKI, Tomasz | Proceedings Paper | C2 |
| 150 | 2002 | The role of colony stimulating factors in small cell cancer: why the question is still unresolved | Trillet-Lenoir, V.; Piedbois, R.; BUYSE, Marc | Journal Contribution | A1 |
| 151 | 2002 | Equivalence between ovarian suppression and chemotherapy in the adjuvant treatment of endocrine-responsive breast cancer | DiLeo, A.; BUYSE, Marc | Journal Contribution | A1 |
| 152 | 2002 | Validation of surrogate endpoints in multiple randomized clinical trials with discrete outcomes | RENARD, Didier; GEYS, Helena; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 153 | 2001 | Methodology for the validation of surrogate endpoints in multiple randomized experiments | MOLENBERGHS, Geert; ALONSO ABAD, Ariel; BURZYKOWSKI, Tomasz; CORTINAS ABRAHANTES, Jose; GEYS, Helena; RENARD, Didier; SHKEDY, Ziv; TIBALDI, Fabian; BUYSE, Marc | Proceedings Paper | C2 |
| 154 | 2001 | Methodology of the validation of surrogate endpoints in multiple randomized experiments | MOLENBERGHS, Geert; ALONSO ABAD, Ariel; BURZYKOWSKI, Tomasz; CORTINAS ABRAHANTES, Jose; GEYS, Helena; RENARD, Didier; SHKEDY, Ziv; TIBALDI, Fabian; BUYSE, Marc | Proceedings Paper | C2 |
| 155 | 2001 | Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpoints | BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier | Journal Contribution | A1 |
| 156 | 2001 | Re: A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer | BUYSE, Marc; Thirion, Pierre; Carlson, Robert; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; Piedbois, Pascal | Journal Contribution | A1 |
| 157 | 2001 | Evaluation of surrogate endpoints in randomized experiments with mixed discrete and continuous outcomes | MOLENBERGHS, Geert; GEYS, Helena; BUYSE, Marc | Journal Contribution | A1 |
| 158 | 2001 | Should Dukes' B patients receive adjuvant therapy? A statistical perspective | BUYSE, Marc; Piedbois, P | Journal Contribution | A1 |
| 159 | 2000 | Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpoints | BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier | Proceedings Paper | C1 |
| 160 | 2000 | Randomized designs for early trials of new cancer treatments - An overview | BUYSE, Marc | Journal Contribution | A1 |
| 161 | 2000 | Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis | BUYSE, Marc; Thirion, Pierre; Carlson, Robert W.; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; Piedbois, Pascal | Journal Contribution | A1 |
| 162 | 2000 | Meta-analysis: Methods, strengths, and weaknesses | BUYSE, Marc; Piedbois, P; Piedbois, Y; Carlson, RW | Journal Contribution | A1 |
| 163 | 2000 | R-2: A useful measure of model performance when predicting a dichotomous outcome | BUYSE, Marc | Journal Contribution | A1 |
| 164 | 2000 | Fraud in medical research: An international survey of biostatisticians | Ranstam, J.; BUYSE, Marc; George, S.L.; Evans, S.; Geller, N.; Scherrer, B.; LESAFFRE, Emmanuel; Murray, G.; Edler, L.; Hutton, J.; Colton, T.; Lachenbruch, P. | Journal Contribution | A1 |
| 165 | 2000 | Statistical validation of surrogate endpoints: problems and proposals | BUYSE, Marc; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena | Journal Contribution | A1 |
| 166 | 2000 | Corrigendum to "The validation of surrogate endpoints in randomized experiments" | BUYSE, Marc; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz | Journal Contribution | M |
| 167 | 2000 | The validation of surrogate endpoints in meta-analyses of randomized experiments | BUYSE, Marc; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena | Journal Contribution | A1 |
| 168 | 1999 | The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials | BUYSE, Marc; George, SL; Evans, S; Geller, NL; Ranstam, J; Scherrer, B; LESAFFRE, Emmanuel; Murray, G; Edler, L; Hutton, J; Colton, T; Lachenbruch, P; Verma, BL | Journal Contribution | |
| 169 | 1999 | Meta-analyses of published results are unreliable | BUYSE, Marc; Carlson, RW; Piedbois, P | Journal Contribution | |
| 170 | 1999 | The validation of surrogate endpoints in meta-analyses of randomized experiments | BUYSE, Marc; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena | Proceedings Paper | |
| 171 | 1999 | The role of anthracyclines in epithelial ovarian cancer | Vermorken, J.B.; Harper, P.G.; BUYSE, Marc | Journal Contribution | |
| 172 | 1998 | Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production | Corazza, F.; Beguin, Y.; Bergman, P.; André, M.; Fersten, A.; DE VALCK, Chris; Fondu, P.; BUYSE, Marc; Saribau, E. | Journal Contribution | |
| 173 | 1998 | Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced coloractal cancer | BUYSE, Marc | Journal Contribution | |
| 174 | 1998 | Toxiicity of 5-fluorouacil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors | BUYSE, Marc | Journal Contribution | |
| 175 | 1998 | Homeopathy | BUYSE, Marc | Journal Contribution | |
| 176 | 1998 | Criteria for the validation of surrogate endpoints in randomized experiments | BUYSE, Marc; MOLENBERGHS, Geert | Journal Contribution | |
| 177 | 1997 | The trials of Dr. Bernard Fisher: a European perspective on an American episode | Peto, R.; Collins, R.; Sackett, D.; Darbyshire, J.; Babiker, A.; BUYSE, Marc; Stewart, H.; Baum, M.; Goldhirsch, H.; Bonadonna, G.; Valagussa, P.; Rutqvist, L.; Elbourne, D.; Davies, C.; Dalesio, O.; Parmar, M.; Hill, C.; Clarke, M.; Gray, R.; Doll, R. | Journal Contribution | |
| 178 | 1997 | Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases | Pastorino, U.; BUYSE, Marc; Friedel, G.; Ginsberg, R.J.; Girard, P.; Goldstraw, P.; Johnston, M.; McCormack, P.; Pass, H.; Putman, J.B. | Journal Contribution | |
| 179 | 1997 | A biostatistical tribute to Ignaz Philip Semmelweis | BUYSE, Marc | Journal Contribution | |
| 180 | 1997 | Economic implications of hepatic arterial infusion chemotherapy in treatment of nonresectable colorectal liver metastases. Meta-Analysis Group in Cancer | Durand-Zaleski, I.; Roche, B.; BUYSE, Marc; Carlson, R.; O'Connell, M.J.; Rougier, P.; Chang, A.E.; Sondak, V.K.; Kemeny, M.M.; Allen-Merch, T.G.; Fagniez, P.L.; le Bourgeois, J.P.; Piedbois, P. | Journal Contribution | |
| 181 | 1997 | Letter to the editor: artificial neural networks | BUYSE, Marc; Piedbois, P. | Journal Contribution | |
| 182 | 1997 | Artificial neural networks | BUYSE, Marc; Piedbois, P | Journal Contribution | |
| 183 | 1997 | Critical issues in colorectal cancer trial design | Piedbois, P.; BUYSE, Marc; Pignon, J.P. | Journal Contribution | |
| 184 | 1997 | La randomisation dans les essais cliniques | BUYSE, Marc; Piedbois, P. | Journal Contribution | |
| 185 | 1996 | Le 5-fluorouracile...un vieux médicament? | Piedbois, P.; BUYSE, Marc; Gauthier, E.; le Bourgeois, J.P. | Journal Contribution | |
Loading...
5
0
5
0
false